Michael Kuhns named Pew Charitable Trusts investigator
The Kuhns laboratory at the University of Arizona Cancer Center focuses on gaining a better understanding of T cells and how this knowledge can be applied to cancer treatment strategies.
Michael Kuhns, PhD, a professor in the University of Arizona College of Medicine – Tucson and the senior scientific advisor for the Center for Advanced Molecular and Immunological Therapies, or CAMI, has been named to The Pew Charitable Trusts’ 2024 class of Innovation Fund Investigators.
The Pew Charitable Trusts announced Dec. 10 that eight pairs of researchers will make up the latest class of Innovation Fund Investigators. Each pair of investigators will receive $270,000 over the course of three years to conduct their joint research projects.
“It is a great honor to be chosen for support by Pew to ask fundamental basic research questions that entail some element of risk and are unlikely to be funded by more conventional mechanisms,” said Kuhns, who is also a member of the U of A Cancer Center and the BIO5 Institute. “This work will help us understand how time and selective pressure have differentially shaped key molecules that drive T cell activation in fish and mammals after they diverged from a common ancestor.”
Read more on the University of Arizona Health Sciences website.